Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 7, 2002, Pages 1114-1127

  Hsia, Henry H ^a,b   Marchlinski, Francis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiomyopathy; Substrate; Ventricular tachycardia

Indexed keywords

CARDIOMYOPATHY; CHAGAS DISEASE; ELECTROGRAPHY; ENDOCARDIUM; EPICARDIUM; HEART ELECTROPHYSIOLOGY; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; REENTRY ARRHYTHMIA; REVIEW; SARCOIDOSIS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; PATHOPHYSIOLOGY;

CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 0036319003     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01114.x     Document Type: Review

References (93)

1. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
2. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observation in 35 patients
3. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy
4. Factors influencing the one-year mortality of dilated cardiomyopathy
5. Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy
6. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: Electrophysiologic testing and lack of response to antiarrhythmic drug therapy
7. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy
8. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy
9. Demonstration of re-entry within the His-Purkinje system in man
10. Bundle branch reentry: A possible mechanism of ventricular tachycardia
11. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients
12. Sustained bundle branch reentry as a mechanism of clinical tachycardia
13. Clinical spectrum of ventricular tachycardia
14. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplantation
15. Clinicopathologic correlations of the human cardiac conduction system
16. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry
17. Recurrent sustained ventricular tachycardia: 1. Mechanisms
18. Recurrent sustained ventricular tachycardia: 2. Endocardial mapping
19. Continuous local electrical activity: A mechanism of recurrent ventricular tachycardia
20. Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia
21. Recurrent sustained ventricular tachycardia: Structure and ultrastructure of subendocardial regions in which tachycardia originates
22. Time course for reversal of electrophysiological and ultrastructural abnormalities in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs
23. Electrophysiologic and anatomical basis for fractionated electrograms recorded from healed myocardial infarcts
24. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine model
25. Relation of late potentials to site of origin of ventricular tachycardia associated with coronary heart disease
26. Relation between late potentials on body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia
27. Body surface late potentials: Effects of endocardial resection in patients with ventricular tachycardia
28. The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia
29. Endocardial catheter mapping in patients in sinus rhythm: Relationship to underlying heart disease and ventricular arrhythmias
30. Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia
31. Intraoperative electrophysiologic mapping of the ventricles during sinus rhythm in patients with a previous myocardial infarction: Identification of the electrophysiologic substrate of ventricular arrhythmias
32. Epicardial and endocardial activation during sustained ventricular tachycardia in man
33. The incidence and clinical significance of epicardial late potentials in patients with recurrent sustained ventricular tachycardia and coronary artery disease
34. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients
35. Functional and histologic correlation in patients with dilated cardiomyopathy: An integrated evaluation by multivariate analysis
36. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy
37. Electrophysiologic substrate associated with pacing-induced heart failure in dogs: Potential value of programmed stimulation in predicting sudden death
38. Alteration of potassium currents in isolated human ventricular myocytes from patients with terminal heart failure
39. Cellular mechanism of arrhythmias in hypertrophied and failing myocardium
40. Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload
41. Intracellular calcium transients and arrhythmia is isolated heart cells
42. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits
43. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy
44. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy
45. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: Role of increased fibrosis in the generation of reentry
46. Fractionated electrograms in dilated cardiomyopathy: Origin and relation to abnormal conduction
47. Differences in electrophysiological substrate in patients with coronary artery disease and cardiac arrest or ventricular tachycardia: Insights from endocardial mapping and signal averaged electrocardiography
48. Abnormal epicardial and endocardial electrograms in patients with idiopathic dilated cardiomyopathy: Relationship to arrhythmmias
49. Endocardial map ping in humans in sinus rhythm with normal left ventricles: Activation patterns and characteristics of electrograms
50. Intraoperative activation mapping of ventricular tachycardia
51. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of VT late after myocardial infarction
52. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: In vitro and in vivo accuracy results
53. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy
54. Validation of a new non-contact catheter system for electroanatomic mapping of left ventricular endocardium
55. Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia
56. Mapping and ablation of ventricular tachycardia guided by virtual electrograms using a noncontact, computerized mapping system
57. Prediction of serious arrhythmic events after myocardial infarction: Signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography
58. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring
59. Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia
60. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation
61. Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death
62. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy
63. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: Relationship to sustained ventricular tachyarrhythmias
64. Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy
65. The signal averaged electrocardiogram and programmed stimulation in patients with complex ventricular arrhythmias
66. Relationship of signal averaged ECG and late epicardial electrograms to inducible arrhythmias in patients with idiopathic cardiomyopathy
67. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis
68. Manifestations of sarcoidosis: Analysis of 145 patients, with a review of nine series selected from the literature
69. Rapid progressive heart failure resulting from cardiac sarcoidosis
70. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)
71. Sarcoidosis: A pattern of clinical and morphological presentation
72. Cardiac sarcoidosis with sudden death: Treatment with the automatic implantable cardioverter defibrillator
73. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device
74. A comparison of two syndromes causing multiple different ventricular tachycardias in young patients with minimal ventricular dysfunction: Cardiac sarcoid and a new clinical entity
75. Right ventricular dysplasia: A report of 24 adult cases
76. Comparison of two-dimensional echocardiographic and angiographic findings in arrhythmogenic right ventricular dysplasia
77. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy
78. Nonischemic sustained ventricular tachycardia: Clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia
79. Arrhythmogenic right ventricular dysplasia: MRI findings
80. Fulguration of chronic ventricular tachycardia: Results of forty-seven consecutive cases with a follow-up ranging from 11 to 65 months
81. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia
82. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy
83. Electroanatomic substrate for ventricular tachycardia in the setting of right ventricular cardiomyopathy
84. Cardiac morbidity and mortality due to Chagas' disease: Prospective electrocardiographic study of a Brazilian community
85. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man
86. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy
87. Sustained ventricular tachycardia in chronic chagasic myocarditis: Electrophysiologic and pharmacologic characteristics
88. Ventricular tachycardia in Chagas' disease
89. Electrophysiologic study in chronic Chagas' heart disease
90. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia
91. Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart disease
92. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction
93. Epicardial mapping and radiofrequency catheter ablation of ischemic ventricular tachycardia using a three-dimensional nonfluoroscopic mapping system